Airway-specific autoantibodies identify a subset of patients with fibrotic interstitial lung disease

Approach to the Patient with Interstitial Lung Disease

Association study of human leukocyte antigen (HLA) variants and idiopathic pulmonary fibrosis

Cluster analysis of transcriptomic datasets to identify endotypes of Idiopathic Pulmonary Fibrosis

Faculty Opinions recommendation of A common MUC5B promoter polymorphism and pulmonary fibrosis.

Faculty Opinions recommendation of A placebo-controlled randomized trial of warfarin in idiopathic pulmonary fibrosis.

Faculty Opinions recommendation of A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis.

Faculty Opinions recommendation of Acute exacerbation of idiopathic pulmonary fibrosis associated with air pollution exposure.

Faculty Opinions recommendation of Allosteric inhibition of lysyl oxidase-like-2 impedes the development of a pathologic microenvironment.

Faculty Opinions recommendation of An official ATS/ERS/JRS/ALAT clinical practice guideline: treatment of idiopathic pulmonary fibrosis. an update of the 2011 clinical practice guideline.

Faculty Opinions recommendation of Antifibrotic action of pirfenidone and prednisolone: different effects on pulmonary cytokines and growth factors in bleomycin-induced murine pulmonary fibrosis.

Faculty Opinions recommendation of Ascertainment of individual risk of mortality for patients with idiopathic pulmonary fibrosis.

Faculty Opinions recommendation of Baseline KL-6 predicts increased risk for acute exacerbation of idiopathic pulmonary fibrosis.

Faculty Opinions recommendation of Bronchoscopic lung cryobiopsy increases diagnostic confidence in the multidisciplinary diagnosis of idiopathic pulmonary fibrosis.

Faculty Opinions recommendation of Cellular interactions in the pathogenesis of interstitial lung diseases.

Faculty Opinions recommendation of Classification of usual interstitial pneumonia in patients with interstitial lung disease: assessment of a machine learning approach using high-dimensional transcriptional data.

Faculty Opinions recommendation of Delayed access and survival in idiopathic pulmonary fibrosis: a cohort study.

Faculty Opinions recommendation of Discovery and validation of extracellular/circulating microRNAs during idiopathic pulmonary fibrosis disease progression.

Faculty Opinions recommendation of Double-blind, placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis.

Faculty Opinions recommendation of Effect of telomere length on survival in patients with idiopathic pulmonary fibrosis: an observational cohort study with independent validation.

Faculty Opinions recommendation of Efficacy of a tyrosine kinase inhibitor in idiopathic pulmonary fibrosis.

Faculty Opinions recommendation of Epigenetics of idiopathic pulmonary fibrosis.

Faculty Opinions recommendation of Expression analysis of serum microRNAs in idiopathic pulmonary fibrosis.

Faculty Opinions recommendation of Extensive phenotyping of individuals at risk for familial interstitial pneumonia reveals clues to the pathogenesis of interstitial lung disease.

Faculty Opinions recommendation of Familial and sporadic idiopathic pulmonary fibrosis: making the diagnosis from peripheral blood.

Faculty Opinions recommendation of Fibulin-1 predicts disease progression in patients with idiopathic pulmonary fibrosis.

Faculty Opinions recommendation of Glutathione deficiency in the epithelial lining fluid of the lower respiratory tract in idiopathic pulmonary fibrosis.

Faculty Opinions recommendation of Glycolytic reprogramming in myofibroblast differentiation and lung fibrosis.

Faculty Opinions recommendation of Heterogeneous gene expression signatures correspond to distinct lung pathologies and biomarkers of disease severity in idiopathic pulmonary fibrosis.

Faculty Opinions recommendation of High-dose acetylcysteine in idiopathic pulmonary fibrosis.

Faculty Opinions recommendation of Idiopathic pulmonary fibrosis: CT and risk of death.

Faculty Opinions recommendation of Incidence and prevalence of idiopathic pulmonary fibrosis.

Faculty Opinions recommendation of Increased alveolar soluble annexin V promotes lung inflammation and fibrosis.

Faculty Opinions recommendation of Influenza promotes collagen deposition via αvβ6 integrin-mediated transforming growth factor β activation.

Faculty Opinions recommendation of Inhibition of PDGF, VEGF and FGF signalling attenuates fibrosis.

Faculty Opinions recommendation of Interaction of IL-13 and C10 in the pathogenesis of bleomycin-induced pulmonary fibrosis.

Faculty Opinions recommendation of Lung fibroblasts from patients with idiopathic pulmonary fibrosis exhibit genome-wide differences in DNA methylation compared to fibroblasts from nonfibrotic lung.

Faculty Opinions recommendation of Lung microbiome and disease progression in idiopathic pulmonary fibrosis: an analysis of the COMET study.

Faculty Opinions recommendation of MicroRNA mimicry blocks pulmonary fibrosis.

Faculty Opinions recommendation of Molecular biomarkers in idiopathic pulmonary fibrosis.

Faculty Opinions recommendation of Non-steroid agents for idiopathic pulmonary fibrosis.

Faculty Opinions recommendation of Partial inhibition of integrin alpha(v)beta6 prevents pulmonary fibrosis without exacerbating inflammation.

Faculty Opinions recommendation of Pirfenidone in idiopathic pulmonary fibrosis.

Faculty Opinions recommendation of Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials.

Faculty Opinions recommendation of Pirfenidone inhibits the expression of HSP47 in TGF-beta1-stimulated human lung fibroblasts.

Faculty Opinions recommendation of Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis.

Faculty Opinions recommendation of Relationship of DNA methylation and gene expression in idiopathic pulmonary fibrosis.

Faculty Opinions recommendation of Serum lysyl oxidase-like 2 levels and idiopathic pulmonary fibrosis disease progression.

Faculty Opinions recommendation of Sildenafil preserves exercise capacity in patients with idiopathic pulmonary fibrosis and right-sided ventricular dysfunction.

Faculty Opinions recommendation of Staging of idiopathic pulmonary fibrosis: past, present and future.

Faculty Opinions recommendation of TOLLIP, MUC5B, and the Response to N-Acetylcysteine among Individuals with Idiopathic Pulmonary Fibrosis.

Faculty Opinions recommendation of Telomere length in interstitial lung diseases.

Faculty Opinions recommendation of Thalidomide for the treatment of cough in idiopathic pulmonary fibrosis: a randomized trial.

Faculty Opinions recommendation of The code of non-coding RNAs in lung fibrosis.

Faculty Opinions recommendation of The metabolomics of airway diseases, including COPD, asthma and cystic fibrosis.

Faculty Opinions recommendation of The mitochondrial cardiolipin remodeling enzyme lysocardiolipin acyltransferase is a novel target in pulmonary fibrosis.

Faculty Opinions recommendation of The rising incidence of idiopathic pulmonary fibrosis in the U.K.

Faculty Opinions recommendation of Treating idiopathic pulmonary fibrosis with the addition of co-trimoxazole: a randomised controlled trial.

Faculty Opinions recommendation of Unified baseline and longitudinal mortality prediction in idiopathic pulmonary fibrosis.

Faculty Opinions recommendation of αvβ6 integrin may be a potential prognostic biomarker in interstitial lung disease.

Genome-wide SNP-sex interaction analysis of susceptibility to idiopathic pulmonary fibrosis

Genome-wide analysis of longitudinal lung function and gas transfer in individuals with idiopathic pulmonary fibrosis

Identification of a novel missense variant inSPDL1associated with idiopathic pulmonary fibrosis

PCSK6 and Survival in Idiopathic Pulmonary Fibrosis

Proportion of idiopathic pulmonary fibrosis risk explained by known genetic loci